print

Lidewij Henneman wins the EMGO+ Societal Impact Award 2016

Date published: May 24th, 2016

Lidewij Henneman wins the EMGO+ Societal Impact Award 2016

At the EMGO+ Annual Meeting 2016 the Societal Impact Award has been awarded to Lidewij Henneman

Every year the EMGO+ Institute for Health and Care Research awards a prize to the product with the highest societal impact. On May 19th at the EMGO+ Annual Meeting, Lidewij Henneman was awarded the Societal Impact Award for the license application for the implementation of the non-invasive prenatal test (NIPT) in the Netherlands.

The jury stated that the NIPT (a blood test for pregnant women to determine whether the unborn child has an extra chromosome 21 (Down’s syndrome), 13 (Patau syndrome) or 18 (Edwards syndrome)) has high societal impact, as this product has a clear impact for patients; in this case pregnant women and their partner. For most women at high risk for fetal trisomy, invasive tests are now no longer needed and the chances on miscarriage are thus reduced. Henneman contributed to the set-up of a large-scale national study (TRIDENT study) by the Dutch NIPT Consortium, which has given input to the availability of the NIPT for high-risk groups. Additionally, the NIPT has generated a lot of political and societal interest and receives much media attention.

The other nominee was:

Esther Maas (Health Sciences)
Radiofrequency denervation for chronic low back pain no longer insured healthcare.


 

« back to the previous page